We are live on ! Find out more
VVA

Vida Ventures Advisors Portfolio holdings

AUM $29.4M
1-Year Est. Return 93.58%
This Fund
S&P 500
This Quarter Est. Return
-32.25%
1 Year Est. Return
+93.58%
3 Year Est. Return
+153.74%
5 Year Est. Return
+14.63%
10 Year Est. Return
AUM
$91.4M
AUM Growth
-$88.6M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
5
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CNTA
1
DELISTED
Centessa Pharmaceuticals
CNTA
$35.5M 38.83%
3,931,818
KYTX icon
2
Kyverna Therapeutics
KYTX
$481M
$33.9M 37.11%
4,523,924
DYN icon
3
Dyne Therapeutics
DYN
$4.24B
$14.4M 15.73%
407,499
ALLO icon
4
Allogene Therapeutics
ALLO
$604M
$4.19M 4.58%
1,798,163
KRON
5
DELISTED
Kronos Bio
KRON
$3.43M 3.75%
2,765,314

Similar funds

Vida Ventures Advisors's Q2 2024 Portfolio in Review

As of Q2 2024, Vida Ventures Advisors held 5 positions worth $91.4M, down 49% from $180M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q2 2024: portfolio turnover was 0%. Vida Ventures Advisors opened no new positions and made no exits, leaving the 5-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Vida Ventures Advisors's ten largest holdings make up 100% of its $91.4M portfolio in Q2 2024.
  • Vida Ventures Advisors opened 0 new positions and closed 0 in Q2 2024.
  • Vida Ventures Advisors's portfolio value fell 49% quarter-over-quarter to $91.4M.

Based on Vida Ventures Advisors's 13F filing for Q2 2024, filed 10 Jul 2024.